Celularity, Inc. (CELU)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GX Acquisition Corp. (“GXGX”), which merged with Celularity, Inc. (“Celularity” or the “Company”) (NASDAQ: CELU) on January 8, 2021. Such investors who continue to hold to the present are encouraged to obtain additional information and assist the investigation.
The investigation concerns whether GXGX failed to provide relevant information to its shareholders before the merger.
What’s Next?
If you are aware of any facts relating to this investigation or hold Celularity shares, you can assist this investigation. You can also contact Peretz Bronstein or his Law Clerk and Clients Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Why Bronstein, Gewirtz & Grossman:
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
Attorney advertising. Prior results do not guarantee similar outcomes.